Further Investigation of an Intramuscular Influenza Vaccine (Multimeric-001)
Clinical trial NCT01146119 · COMPLETED
Trial details
- NCT number
- NCT01146119
- Sponsor
- BiondVax Pharmaceuticals ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-05-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.